Mette M Berger1, Annika Reintam-Blaser2, Philip C Calder3, Michael Casaer4, Michael J Hiesmayr5, Konstantin Mayer6, Juan Carlos Montejo7, Claude Pichard8, Jean-Charles Preiser9, Arthur R H van Zanten10, Stephan C Bischoff11, Pierre Singer12. 1. Service of Adult Intensive Care and Burns, Lausanne University Hospital - CHUV, Lausanne, Switzerland. Electronic address: Mette.Berger@chuv.ch. 2. Department of Anaesthesiology and Intensive Care, University of Tartu, Tartu, Estonia; Department of Intensive Care Medicine, Lucern Cantonal Hospital, Lucerne, Switzerland. 3. Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom; NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, United Kingdom. Electronic address: P.C.Calder@soton.ac.uk. 4. Clinical Department and Laboratory of Intensive Care Medicine, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium. Electronic address: michael.casaer@uzleuven.be. 5. Division Cardiac-, Thoracic-, Vascular Anaesthesia and Intensive Care, Medical University Vienna, Waehringerguertel 18-20, A-1090 Vienna, Austria. Electronic address: michael.hiesmayr@meduniwien.ac.at. 6. Universitätsklinikum Gießen Medizinische, Klinikstr. 33, 35392 Gießen, Germany. Electronic address: Konstantin.Mayer@innere.med.uni-giessen.de. 7. Intensive Care Department, Universitary Hospital 12 de Octubre, Madrid, Spain; Surgery Department, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain. Electronic address: jmontejohdoc@gmail.com. 8. Clinical Nutrition, Geneva University Hospital, Geneva, Switzerland. Electronic address: Claude.Pichard@unige.ch. 9. Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Belgium. Electronic address: Jean-Charles.Preiser@erasme.ulb.ac.be. 10. Department of Intensive Care, Gelderse Vallei Hospital, Willy Brandtlaan 10, 6716 RP Ede, The Netherlands. Electronic address: zantena@zgv.nl. 11. Department of Nutritional Medicine/Prevention, University of Hohenheim, Fruwirthstrasse 12, 70593 Stuttgart, Germany. Electronic address: bischoff.stephan@uni-hohenheim.de. 12. Department of General Intensive Care, Institute for Nutrition Research, Rabin Medical Center, Beilinson Hospital, Sackler School of Medicine, Tel Aviv University, Israel. Electronic address: pierre.singer@gmail.com.
Abstract
BACKGROUND & AIMS: This position paper summarizes theoretical and practical aspects of the monitoring of artificial nutrition and metabolism in critically ill patients, thereby completing ESPEN guidelines on intensive care unit (ICU) nutrition. METHODS: Available literature and personal clinical experience on monitoring of nutrition and metabolism was systematically reviewed by the ESPEN group for ICU nutrition guidelines. RESULTS: We did not identify any studies comparing outcomes with monitoring versus not monitoring nutrition therapy. The potential for abnormal values to be associated with harm was clearly recognized. The necessity to create locally adapted standard operating procedures (SOPs) for follow up of enteral and parenteral nutrition is emphasised. Clinical observations, laboratory parameters (including blood glucose, electrolytes, triglycerides, liver tests), and monitoring of energy expenditure and body composition are addressed, focusing on prevention, and early detection of nutrition-related complications. CONCLUSION: Understanding and defining risks and developing local SOPs are critical to reduce specific risks.
BACKGROUND & AIMS: This position paper summarizes theoretical and practical aspects of the monitoring of artificial nutrition and metabolism in critically illpatients, thereby completing ESPEN guidelines on intensive care unit (ICU) nutrition. METHODS: Available literature and personal clinical experience on monitoring of nutrition and metabolism was systematically reviewed by the ESPEN group for ICU nutrition guidelines. RESULTS: We did not identify any studies comparing outcomes with monitoring versus not monitoring nutrition therapy. The potential for abnormal values to be associated with harm was clearly recognized. The necessity to create locally adapted standard operating procedures (SOPs) for follow up of enteral and parenteral nutrition is emphasised. Clinical observations, laboratory parameters (including blood glucose, electrolytes, triglycerides, liver tests), and monitoring of energy expenditure and body composition are addressed, focusing on prevention, and early detection of nutrition-related complications. CONCLUSION: Understanding and defining risks and developing local SOPs are critical to reduce specific risks.
Authors: Jan Wernerman; Kenneth B Christopher; Djillali Annane; Michael P Casaer; Craig M Coopersmith; Adam M Deane; Elisabeth De Waele; Gunnar Elke; Carole Ichai; Constantine J Karvellas; Stephen A McClave; Heleen M Oudemans-van Straaten; Olav Rooyackers; Renee D Stapleton; Jukka Takala; Arthur R H van Zanten; Paul E Wischmeyer; Jean-Charles Preiser; Jean-Louis Vincent Journal: Crit Care Date: 2019-09-18 Impact factor: 9.097
Authors: Lourdes Herrera-Quintana; Yenifer Gamarra-Morales; Héctor Vázquez-Lorente; Jorge Molina-López; José Castaño-Pérez; Juan Francisco Machado-Casas; Ramón Coca-Zúñiga; José Miguel Pérez-Villares; Elena Planells Journal: Nutrients Date: 2021-06-09 Impact factor: 5.717